Cancel
OK

You have successfully logged out.

Hello !
chevron_right My profile
chevron_right To My B. Braun overview
Logout

Each individual patient in mind

Personalized treatments ​in hemodialysis

Personalized treatments mean shaping treatment around the individual — their clinical needs, vascular access,

symptoms, goals and day-to-day experience — rather than relying on a one-size-fits-all approach.

  • Almost

    0%

    of patients in the UK do not achieve the treatment efficacy target of URR >65%.1

  • More than

    0%

    of patients experience​ IDH or hypotension during dialysis.2,3

  • Up to

    0%

    Hemodialysis patients experience vascular access – related hospital admission per year.4

A dialysis patient leaning over a dialysis chair, looking comfortable and relaxed.

Turning renal care ​into real care​

For us, real care begins with responsibility toward patients, caregivers and the world we share. It starts with personalized treatments tailored to each patient and extends to sustainable solutions. That is why we develop technologies and products that help reduce the environmental impact of dialysis by reducing water and energy consumption, waste and CO2 emissions while supporting high-quality care. This sense of responsibility shapes everything we do. That is what we mean by real care.​

Learn more

Toward more personalized renal care​

Personalized treatments tailored to individual needs​

Every dialysis patient is different — in symptoms, treatment response, vascular access, fluid balance and personal care goals. Personalized renal care aims to help care teams to see and respond to those differences. By following each patient’s changing needs across the dialysis journey, care teams can make more deliberate, patient-centered choices — helping treatment feel better aligned with the person behind the prescription.

Improving treatment adequacy in renal care​

Dialysis adequacy can vary from session to session. Greater real-time visibility of dose, clearance trends and treatment stability can help care teams recognize when a treatment may need attention.

Personalized care therefore means making adequacy and treatment response more visible in real time so teams can respond more confidently for each individual patient.​

A nephrologist showing a dialysis nurse something on an iPad in a treatment room at a renal care center, with a patient in the background.
patient-listenting-to-music-landscape-1000x563px.jpg

Caring for fistula health in renal care​

Fistula health is critical for successful dialysis, yet not all patients face the same vascular access conditions. Vascular access challenges, temporary catheter use or treatment interruptions can make dialysis care and outcomes more complex and may reduce quality of life. Personalized treatment planning helps keep continuity, safety and patient comfort in focus.5

Learn more

Improving symptom management in renal care​

Fluid management and treatment stability matter because they are closely linked with how patients feel during and after dialysis. Fluid management and treatment stability have a direct impact on well-being, symptoms and hospitalization risk. Some people do well with standard dialysis settings. Others need closer attention to blood pressure, fluid removal, recovery time or recurring treatment burden. Personalized dialysis aims to support care that responds to individual patient differences with empathy and precision.

A dialysis patient in a treatment room at a renal care center, smiling and looking comfortable.
Nurse Tamasin Stevenson​

“Individualized care is about understanding what matters to each patient and helping them live as normal life as possible, without having to worry about dialysis or being in pain. With personalized treatment, I’m helping my patients manage their care and work towards their goals.”

Tami, Vascular Access Lead BUH​

Get in touch with our personalized treatments experts

The responsible organization is B. Braun Avitum AG

I can revoke my consent at any time by sending an e-mail to info(@)bbraun.com or by clicking on the unsubscribe link at the end of any marketing e-mail. For more information about the processing of your data and your data protection rights, please refer to our privacy notice.

Thank you for your interest!

check_circle

You will be contacted by our Hemodialysis Experts. Kindly check your inbox and confirm the e-mail we've sent you.

Your request could not be submitted. Please try again.

warning

References

  1. UK Renal Registry. UK Renal Registry 26th Annual Report – Data to 31/12/2022. Bristol, UK: UK Kidney Association; 2024.
  2. Arcentales-Vera K, Vera-Mendoza MF, Cevallos-Salas C, García-Aguilera MF, Fuenmayor-González L. Prevalence of cardiovascular instability during hemodialysis therapy in hospitalized patients: A systematic review and meta-analysis. Science Progress. 2024;107(4):00368504241308982. doi: 10.1177/00368504241308982
  3. Kuipers J, Verboom LM, Ipema KJR, Paans W, Krijnen WP, Gaillard CAJM, Westerhuis R, Franssen CFM. The Prevalence of Intradialytic Hypotension in Patients on Conventional Hemodialysis: A Systematic Review with Meta-Analysis. American Journal of Nephrology. 2019;49(6):497-506. doi: 10.1159/000500877
  4. Luzardo L, Zinoveev MA, Ceretta ML, Ferreiro A, Gonzalez-Bedat MC. Vascular Access-Related Hospitalizations in Hemodialysis. J Am Soc Nephrol. 2024;35(10 Suppl):FR-PO546. doi:10.1681/ASN.2024n1526d2r.
  5. Lok CE, Huber TS, Lee T, et al; KDOQI Vascular Access Guideline Work Group. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4)(suppl 2):S1-S164.

Take part in our customer survey

Your feedback matters! Participate in our customer survey to help us enhance our website, products and services. Thank you for your support!

Start survey